Overexpression of AMPKγ2 increases AMPK signaling to augment human T cell metabolism and function
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved..
Cellular therapies are currently employed to treat a variety of disease processes. For T cell-based therapies, success often relies on the metabolic fitness of the T cell product, where cells with enhanced metabolic capacity demonstrate improved in vivo efficacy. AMP-activated protein kinase (AMPK) is a cellular energy sensor which combines environmental signals with cellular energy status to enforce efficient and flexible metabolic programming. We hypothesized that increasing AMPK activity in human T cells would augment their oxidative capacity, creating an ideal product for adoptive cellular therapies. Lentiviral transduction of the regulatory AMPKγ2 subunit stably enhanced intrinsic AMPK signaling and promoted mitochondrial respiration with increased basal oxygen consumption rates, higher maximal oxygen consumption rate, and augmented spare respiratory capacity. These changes were accompanied by increased proliferation and inflammatory cytokine production, particularly within restricted glucose environments. Introduction of AMPKγ2 into bulk CD4 T cells decreased RNA expression of canonical Th2 genes, including the cytokines interleukin (IL)-4 and IL-5, while introduction of AMPKγ2 into individual Th subsets universally favored proinflammatory cytokine production and a downregulation of IL-4 production in Th2 cells. When AMPKγ2 was overexpressed in regulatory T cells, both in vitro proliferation and suppressive capacity increased. Together, these data suggest that augmenting intrinsic AMPK signaling via overexpression of AMPKγ2 can improve the expansion and functional potential of human T cells for use in a variety of adoptive cellular therapies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:300 |
|---|---|
| Enthalten in: |
The Journal of biological chemistry - 300(2024), 1 vom: 17. Jan., Seite 105488 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Braverman, Erica L [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 07.02.2024 Date Revised 27.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jbc.2023.105488 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364919086 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364919086 | ||
| 003 | DE-627 | ||
| 005 | 20240229163810.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jbc.2023.105488 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1308.xml |
| 035 | |a (DE-627)NLM364919086 | ||
| 035 | |a (NLM)38000657 | ||
| 035 | |a (PII)S0021-9258(23)02516-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Braverman, Erica L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Overexpression of AMPKγ2 increases AMPK signaling to augment human T cell metabolism and function |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.02.2024 | ||
| 500 | |a Date Revised 27.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Cellular therapies are currently employed to treat a variety of disease processes. For T cell-based therapies, success often relies on the metabolic fitness of the T cell product, where cells with enhanced metabolic capacity demonstrate improved in vivo efficacy. AMP-activated protein kinase (AMPK) is a cellular energy sensor which combines environmental signals with cellular energy status to enforce efficient and flexible metabolic programming. We hypothesized that increasing AMPK activity in human T cells would augment their oxidative capacity, creating an ideal product for adoptive cellular therapies. Lentiviral transduction of the regulatory AMPKγ2 subunit stably enhanced intrinsic AMPK signaling and promoted mitochondrial respiration with increased basal oxygen consumption rates, higher maximal oxygen consumption rate, and augmented spare respiratory capacity. These changes were accompanied by increased proliferation and inflammatory cytokine production, particularly within restricted glucose environments. Introduction of AMPKγ2 into bulk CD4 T cells decreased RNA expression of canonical Th2 genes, including the cytokines interleukin (IL)-4 and IL-5, while introduction of AMPKγ2 into individual Th subsets universally favored proinflammatory cytokine production and a downregulation of IL-4 production in Th2 cells. When AMPKγ2 was overexpressed in regulatory T cells, both in vitro proliferation and suppressive capacity increased. Together, these data suggest that augmenting intrinsic AMPK signaling via overexpression of AMPKγ2 can improve the expansion and functional potential of human T cells for use in a variety of adoptive cellular therapies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a AMP-activated protein kinase | |
| 650 | 4 | |a AMPK | |
| 650 | 4 | |a Th1 | |
| 650 | 4 | |a Th2 | |
| 650 | 4 | |a Treg | |
| 650 | 4 | |a glucose restriction | |
| 650 | 4 | |a glycolysis | |
| 650 | 4 | |a immunometabolism | |
| 650 | 4 | |a memory T cells | |
| 650 | 4 | |a oxidative metabolism | |
| 650 | 4 | |a spare respiratory capacity | |
| 650 | 7 | |a AMP-Activated Protein Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.11.31 |2 NLM | |
| 650 | 7 | |a Cytokines |2 NLM | |
| 650 | 7 | |a PRKAG2 protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a Glucose |2 NLM | |
| 650 | 7 | |a IY9XDZ35W2 |2 NLM | |
| 700 | 1 | |a McQuaid, Margaret A |e verfasserin |4 aut | |
| 700 | 1 | |a Schuler, Herbert |e verfasserin |4 aut | |
| 700 | 1 | |a Qin, Mengtao |e verfasserin |4 aut | |
| 700 | 1 | |a Hani, Sophia |e verfasserin |4 aut | |
| 700 | 1 | |a Hippen, Keli |e verfasserin |4 aut | |
| 700 | 1 | |a Monlish, Darlene A |e verfasserin |4 aut | |
| 700 | 1 | |a Dobbs, Andrea K |e verfasserin |4 aut | |
| 700 | 1 | |a Ramsey, Manda J |e verfasserin |4 aut | |
| 700 | 1 | |a Kemp, Felicia |e verfasserin |4 aut | |
| 700 | 1 | |a Wittmann, Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Ramgopal, Archana |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Harrison |e verfasserin |4 aut | |
| 700 | 1 | |a Blazar, Bruce |e verfasserin |4 aut | |
| 700 | 1 | |a Byersdorfer, Craig A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of biological chemistry |d 1945 |g 300(2024), 1 vom: 17. Jan., Seite 105488 |w (DE-627)NLM000004995 |x 1083-351X |7 nnns |
| 773 | 1 | 8 | |g volume:300 |g year:2024 |g number:1 |g day:17 |g month:01 |g pages:105488 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jbc.2023.105488 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 300 |j 2024 |e 1 |b 17 |c 01 |h 105488 | ||